Health
How the once-blacklisted Dr. Jay Bhattacharya could help save healthcare

From LifeSiteNews
Now seated at the helm of the National Institutes of Health, Dr. Jay Bhattacharya is poised to reshape not only the agency’s research priorities but the very culture that pushed him to the fringe.
Imagine spending your career studying infectious diseases, only to find that the real virus spreading uncontrollably is censorship. That was the reality for Dr. Jay Bhattacharya, a Stanford epidemiologist who committed the unpardonable sin of questioning the COVID-19 lockdown orthodoxy. His punishment? Digital exile, courtesy of Silicon Valley’s Ministry of Truth.
In December 2022, the Twitter Files exposed what many had long suspected: Twitter had quietly placed Bhattacharya’s account on a Trends Blacklist. This ensured that his posts, often critical of lockdowns and mask mandates, would never see the light of day on the platform’s trending topics. In other words, Twitter’s algorithm worked like a digital bouncer, making sure his dissenting opinions never made it past the velvet rope.
And Twitter wasn’t alone. Facebook, ever eager to please its government handlers, scrubbed the Great Barrington Declaration from its pages. That document, co-authored by Bhattacharya and other esteemed scientists, dared to suggest that maybe, just maybe, locking down entire populations wasn’t the best strategy. Instead, it proposed focused protection for the most vulnerable while allowing the rest of society to function. For this, it was sent to the digital equivalent of a gulag.
These experiences took center stage during Bhattacharya’s Senate confirmation hearing for the directorship of the National Institutes of Health (NIH). Republican lawmakers, who suddenly found themselves cast as the last defenders of free speech in scientific discourse, saw his nomination as a win.
During his testimony, Bhattacharya didn’t mince words. He detailed how the Biden administration played an active role in orchestrating the suppression of alternative views. It wasn’t enough for officials to push their own pandemic policies — they needed to ensure that no one, regardless of expertise, could challenge them in the public square.
The Science™ vs. The Science
Bhattacharya’s testimony laid bare an uncomfortable truth: the pandemic was a crisis of speech. “The root problem was that people who had alternative ideas were suppressed,” he told Sen. Ashley Moody (R-Fla.). “I personally was subject to censorship by the actions of the Biden administration during the pandemic.”
In a functioning society, that statement would spark bipartisan outrage. Instead, it barely registered. The people who spent years chanting “trust the science” were never interested in science at all.
Real science thrives on debate, skepticism, and the understanding that no single expert — no matter how credentialed—holds absolute truth. But during COVID, science became The Science™ — a government-approved doctrine enforced by Silicon Valley moderators and federal bureaucrats. Deviate from it, and you weren’t just wrong. You were dangerous.
A government-sanctioned muzzle
Bhattacharya wasn’t silenced in some haphazard, accidental way. The Biden administration actively leaned on social media companies to “moderate” voices like his. In practice, that meant tech executives — most of whom couldn’t tell a virus from a viral tweet — decided which epidemiologists the public was allowed to hear.
He responded with a lawsuit against the administration, accusing it of colluding with Big Tech to crush dissent. But in a ruling as predictable as it was revealing, the Supreme Court dismissed the case, arguing that Bhattacharya and his fellow plaintiffs lacked standing. Meaning: Yes, the government may have pressured private companies into silencing critics, but unless you can prove exactly how that harmed you, don’t expect the courts to care.
The real role of science
Despite everything, Bhattacharya didn’t argue for scientists to dictate policy. Unlike the public health bureaucrats who spent the pandemic issuing commandments from their Zoom thrones, he made it clear: “Science should be an engine for freedom,” he said. “Not something where it stands on top of society and says, ‘You must do this, this or this, or else.’”
That distinction matters. Science informs, but policy is about trade-offs. The problem wasn’t that officials got things wrong — it’s that they refused to admit the possibility. Instead of allowing open debate, they silenced critics. Instead of acknowledging uncertainty, they imposed rules with absolute certainty.
Bhattacharya wasn’t censored because he was wrong. He was censored because he questioned people who couldn’t afford to be.
His confirmation hearing made one thing clear: science wasn’t about data. It was about power. And in Washington, power doesn’t like to be questioned.
Science, money and power
At the heart of the hearing was a fundamental question: Who controls science that people are allowed to talk about? The NIH, with its $48 billion budget, is less a research institution and more a financial leviathan, shaping the direction of American science through the projects it funds (or doesn’t) fund.
Bhattacharya’s nomination comes at a moment when the battle lines around scientific freedom, government intervention, and public trust in research are more entrenched than ever. The pandemic shattered the illusion that science was above politics. Instead, it exposed just how much political and corporate interests shape what counts as “settled” science.
The irony is thick enough to cut with a knife. The man once branded too dangerous for social media, blacklisted for questioning lockdowns, and effectively erased from mainstream discourse is now being handed a key role in the very government that tried to silence him. Dr. Jay Bhattacharya, once forced to the margins, is now at the center of power.
A new administration has decided that maybe — just maybe — silencing dissenting scientists wasn’t the best pandemic strategy. And in a twist no Hollywood scriptwriter would dare to pitch for being too on-the-nose, Bhattacharya wasn’t being welcomed back into the conversation — he’s being put in charge of it.
Bhattacharya was confirmed following a party-line vote Tuesday evening. The decision came after a similarly partisan endorsement from the Senate Committee on Health, Education, Labor and Pensions (HELP), clearing the final hurdle for President Donald Trump’s nominee.
Equally central to his testimony was Bhattacharya’s call for a sweeping shift in NIH priorities. He proposed a decentralization of research funding, stressing the need for greater inclusion of dissenting voices in the scientific process, an apparent rebuke of the consensus-driven culture that dominated during the pandemic. He emphasized targeting resources toward projects with a clear and measurable impact on public health, dismissing other NIH initiatives as “frivolous.”
Now seated at the helm of the National Institutes of Health, Dr. Jay Bhattacharya is poised to reshape not only the agency’s research priorities but the very culture that pushed him to the fringe. His confirmation, hard-won and unapologetically political, is already shaking the scaffolding of a scientific establishment that long equated conformity with consensus.
Reprinted with permission from Reclaim The Net.
Addictions
There’s No Such Thing as a “Safer Supply” of Drugs

By Adam Zivo
Sweden, the U.K., and Canada all experimented with providing opioids to addicts. The results were disastrous.
[This article was originally published in City Journal, a public policy magazine and website published by the Manhattan Institute for Policy Research. We encourage our readers to subscribe to them for high-quality analysis on urban issues]
Last August, Denver’s city council passed a proclamation endorsing radical “harm reduction” strategies to address the drug crisis. Among these was “safer supply,” the idea that the government should give drug users their drug of choice, for free. Safer supply is a popular idea among drug-reform activists. But other countries have already tested this experiment and seen disastrous results, including more addiction, crime, and overdose deaths. It would be foolish to follow their example.
The safer-supply movement maintains that drug-related overdoses, infections, and deaths are driven by the unpredictability of the black market, where drugs are inconsistently dosed and often adulterated with other toxic substances. With ultra-potent opioids like fentanyl, even minor dosing errors can prove fatal. Drug contaminants, which dealers use to provide a stronger high at a lower cost, can be just as deadly and potentially disfiguring.
Because of this, harm-reduction activists sometimes argue that governments should provide a free supply of unadulterated, “safe” drugs to get users to abandon the dangerous street supply. Or they say that such drugs should be sold in a controlled manner, like alcohol or cannabis—an endorsement of partial or total drug legalization.
But “safe” is a relative term: the drugs championed by these activists include pharmaceutical-grade fentanyl, hydromorphone (an opioid as potent as heroin), and prescription meth. Though less risky than their illicit alternatives, these drugs are still profoundly dangerous.
The theory behind safer supply is not entirely unreasonable, but in every country that has tried it, implementation has led to increased suffering and addiction. In Europe, only Sweden and the U.K. have tested safer supply, both in the 1960s. The Swedish model gave more than 100 addicts nearly unlimited access through their doctors to prescriptions for morphine and amphetamines, with no expectations of supervised consumption. Recipients mostly sold their free drugs on the black market, often through a network of “satellite patients” (addicts who purchased prescribed drugs). This led to an explosion of addiction and public disorder.
Most doctors quickly abandoned the experiment, and it was shut down after just two years and several high-profile overdose deaths, including that of a 17-year-old girl. Media coverage portrayed safer supply as a generational medical scandal and noted that the British, after experiencing similar problems, also abandoned their experiment.
While the U.S. has never formally adopted a safer-supply policy, it experienced something functionally similar during the OxyContin crisis of the 2000s. At the time, access to the powerful opioid was virtually unrestricted in many parts of North America. Addicts turned to pharmacies for an easy fix and often sold or traded their extra pills for a quick buck. Unscrupulous “pill mills” handed out prescriptions like candy, flooding communities with OxyContin and similar narcotics. The result was a devastating opioid epidemic—one that rages to this day, at a cumulative cost of hundreds of thousands of American lives. Canada was similarly affected.
The OxyContin crisis explains why many experienced addiction experts were aghast when Canada greatly expanded access to safer supply in 2020, following a four-year pilot project. They worried that the mistakes of the recent past were being made all over again, and that the recently vanquished pill mills had returned under the cloak of “harm reduction.”
Subscribe for free to get BTN’s latest news and analysis – or donate to our investigative journalism fund.
Most Canadian safer-supply prescribers dispense large quantities of hydromorphone with little to no supervised consumption. Patients can receive up to 40 eight-milligram pills per day—despite the fact that just two or three are enough to cause an overdose in someone without opioid tolerance. Some prescribers also provide supplementary fentanyl, oxycodone, or stimulants.
Unfortunately, many safer-supply patients sell or trade a significant portion of these drugs—primarily hydromorphone—in order to purchase more potent illicit substances, such as street fentanyl.
The problems with safer supply entered Canada’s consciousness in mid-2023, through an investigative report I wrote for the National Post. I interviewed 14 addiction physicians from across the country, who testified that safer-supply diversion is ubiquitous; that the street price of hydromorphone collapsed by up to 95 percent in communities where safer supply is available; that youth are consuming and becoming addicted to diverted safer-supply drugs; and that organized crime traffics these drugs.
Facing pushback, I interviewed former drug users, who estimated that roughly 80 percent of the safer-supply drugs flowing through their social circles was getting diverted. I documented dozens of examples of safer-supply trafficking online, representing tens of thousands of pills. I spoke with youth who had developed addictions from diverted safer supply and adults who had purchased thousands of such pills.
After months of public queries, the police department of London, Ontario—where safer supply was first piloted—revealed last summer that annual hydromorphone seizures rose over 3,000 percent between 2019 and 2023. The department later held a press conference warning that gangs clearly traffic safer supply. The police departments of two nearby midsize cities also saw their post-2019 hydromorphone seizures increase more than 1,000 percent.
The Canadian government quietly dropped its support for safer supply last year, cutting funding for many of its pilot programs. The province of British Columbia (the nexus of the harm-reduction movement) finally pulled back support last month, after a leaked presentation confirmed that safer-supply drugs are getting sold internationally and that the government is investigating 60 pharmacies for paying kickbacks to safer-supply patients. For now, all safer-supply drugs dispensed within the province must be consumed under supervision.
Harm-reduction activists have insisted that no hard evidence exists of widespread diversion of safer-supply drugs, but this is only because they refuse to study the issue. Most “studies” supporting safer supply are produced by ideologically driven activist-scholars, who tend to interview a small number of program enrollees. These activists also reject attempts to track diversion as “stigmatizing.”
The experiences of Sweden, the United Kingdom, and Canada offer a clear warning: safer supply is a reliably harmful policy. The outcomes speak for themselves—rising addiction, diversion, and little evidence of long-term benefit.
As the debate unfolds in the United States, policymakers would do well to learn from these failures. Americans should not be made to endure the consequences of a policy already discredited abroad simply because progressive leaders choose to ignore the record. The question now is whether we will repeat others’ mistakes—or chart a more responsible course.
Our content is always free –
but if you want to help us commission more high-quality journalism,
consider getting a voluntary paid subscription.
Health
RFK Jr. says ‘everything is going to change’ with CDC vaccine policy in Michael Knowles interview

From LifeSiteNews
New Health and Human Services Director Robert F. Kennedy Jr. said the CDC’s own reporting system ‘captures fewer than 1% of vaccine injuries. It’s worthless, and everybody agrees it’s worthless.’
When Michael Knowles asked new Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. if anything will change regarding the public’s justifiable concern with the growth of vaccines, Kennedy quickly shot back, “Everything is going to change.”
Kennedy pointed to the Centers for Disease Control’s current flawed VAERS (Vaccine Adverse Event Reporting System) online mechanism.
By way of example, he said, “None of the vaccines that are given during the first six months of life have ever been tested for autism. The only one was the DTP vaccine. And that one study that was done, according to the Institute of Medicine, the National Academy of Sciences, found that there was a link.”
But “They threw out that study because it was based upon CDC’s surveillance system, VAERS, and they said that system is no good.”
“That begs the question, why doesn’t CDC have a functional surveillance system?” he asked. “We’re gonna make sure they do.”
“They don’t do pre-licensing safety testing for vaccines” he continued. “They’re the only product that’s exempt. So what they say is, if there are injuries, we’ll capture them afterward.”
However, “they have a system that doesn’t capture them. In fact, CDC’s own study of its own system said it captures fewer than 1% of vaccine injuries,” Kennedy said. “It’s worthless, and everybody agrees it’s worthless.”
“Why have we gone for 39 years and nobody’s fixed it?” he wondered, promising, “We’re gonna fix it.”
“We have DOGE (which) knows how to manage data. We’re going to be able to get into these databases and give answers to the American public,” Kennedy predicted.
“We’re going to have gold standard science, we’re going to follow the science, we’re going to publish all of our datasets, which CDC has never done,” he said.
“We’re going to do replication of all of our studies, which CDC has never done. We’re going to publish our peer review, which CDC has never done,” Kennedy vowed. “So people are going to have real answers for the first time.”
The new HHS head also discussed more broadly his mission after taking over the department’s helm, the mess created by the Biden administration, his job’s challenges, and recent developments thanks to DOGE.
“HHS is a $1.9 trillion agency. It’s the biggest agency in the government. And during the Biden administration, President Biden increased its budget by 38% and increased the workforce by 17%.”
“And by every metric by which we measure public health, health accelerated its decline.”
“When I came to HHS, what I found was a sprawling bureaucracy,” with functional duplication of departments, rampant redundancy and overstaffing, with various sub-agencies often acting in a territorial, self-protecting manner rather than a synergistic one.
“Perverse incentives” sometimes drive employee’s work,” he noted.
Despite his short tenure at HHS, with the help of DOGE, Kennedy has already released 20,000 “bureaucrats” from the department’s ranks.
“We’re going from 82,000 personnel to 62,000,” said Kennedy, carefully pointing out, “We’re keeping the scientists and frontline providers.”
Kennedy said that it has been really hard to fight against the problems at HHS and NIH over the last 40 years from “the outside.”
But “now I’m on the inside,” he declared. “This is the purpose of my life. It’s what I’m going to do over the next four years.”
He concluded:
President Trump promised to return the American dream to Americans.
A healthy person has a thousand dreams. A sick person only has one.
-
Uncategorized8 hours ago
Poilievre on 2025 Election Interference – Carney sill hasn’t fired Liberal MP in Chinese election interference scandal
-
Business18 hours ago
Cuba has lost 24% of it’s population to emigration in the last 4 years
-
Business2 days ago
Labor Department cancels “America Last” spending spree spanning five continents
-
2025 Federal Election1 day ago
Canadian Banks Tied to Chinese Fentanyl Laundering Risk U.S. Treasury Sanctions After Cartel Terror Designation
-
Health2 days ago
RFK Jr. says ‘everything is going to change’ with CDC vaccine policy in Michael Knowles interview
-
Automotive2 days ago
Trump warns U.S. automakers: Do not raise prices in response to tariffs
-
2025 Federal Election2 days ago
Next federal government should recognize Alberta’s important role in the federation
-
Business1 day ago
Tariff-driven increase of U.S. manufacturing investment would face dearth of workers